Day 2

 

Please find the session links next to their corresponding agenda item.

Thursday, November 10

11:00 AM 

FDLI Welcome and Announcements

Enter this session: https://fdli.zoom.us/j/87087617765

11:05 AM–12:05 PM 

Biologics and Biosimilars
Jacqueline R. Berman, Partner, Morgan, Lewis & Bockius LLP

Enter this session: https://fdli.zoom.us/j/87087617765

12:05–12:20 PM 

Break

12:20–1:20 PM 

Regulation of Over-the-Counter (OTC) Drugs
Benjamin M. Zegarelli, Of Counsel, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Enter this session: https://fdli.zoom.us/j/83883506397

1:20–1:35 PM

Break

1:35–2:35 PM

Regulation of Drug Manufacturing
Scott Kaplan, Partner, Sidley Austin LLP

Enter this session: https://fdli.zoom.us/j/88123350722

2:35–2:50 PM

Break

2:50–3:50 PM

Regulation of Drug Marketing
Stephen E. Nichols, Associate, Shook, Hardy & Bacon LLP

Enter this session: https://fdli.zoom.us/j/88598053576

3:50–4:00 PM

Break

4:00–5:00 PM

Violations and Enforcement
Peter J. Leininger, Partner, King & Spalding LLP

Enter this session: https://fdli.zoom.us/j/81306412108

5:00 PM

Adjournment